Leerink Partners Cuts Align Technology (NASDAQ:ALGN) Price Target to $172.00

Align Technology (NASDAQ:ALGN) had its price target cut by Leerink Partners from $188.00 to $172.00 in a research note released on Tuesday morning,MarketScreener reports. They currently have an outperform rating on the medical equipment provider’s stock.

Other analysts have also recently issued research reports about the company. Weiss Ratings cut Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 8th. Morgan Stanley reissued an “equal weight” rating and set a $154.00 price objective (down previously from $249.00) on shares of Align Technology in a research report on Thursday, July 31st. Jefferies Financial Group reissued a “hold” rating and set a $140.00 price objective (down previously from $215.00) on shares of Align Technology in a research report on Friday, October 10th. Evercore ISI cut their price objective on Align Technology from $170.00 to $160.00 and set an “outperform” rating for the company in a research report on Wednesday, October 8th. Finally, Piper Sandler cut their price objective on Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Align Technology currently has an average rating of “Hold” and a consensus price target of $182.67.

Align Technology Price Performance

Shares of NASDAQ:ALGN opened at $129.84 on Tuesday. Align Technology has a fifty-two week low of $122.00 and a fifty-two week high of $246.19. The business has a 50-day moving average of $134.90 and a two-hundred day moving average of $163.49. The stock has a market capitalization of $9.41 billion, a P/E ratio of 21.90, a P/E/G ratio of 1.46 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the firm earned $2.41 EPS. Align Technology’s quarterly revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. As a group, research analysts expect that Align Technology will post 7.98 EPS for the current fiscal year.

Align Technology declared that its board has authorized a share buyback plan on Tuesday, August 5th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling at Align Technology

In related news, CEO Joseph M. Hogan purchased 7,576 shares of the business’s stock in a transaction dated Friday, August 1st. The shares were bought at an average price of $131.49 per share, with a total value of $996,168.24. Following the purchase, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This trade represents a 4.27% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. 0.66% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ALGN. Rothschild Investment LLC lifted its stake in shares of Align Technology by 140.3% in the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 87 shares during the period. True Wealth Design LLC lifted its stake in shares of Align Technology by 7,650.0% in the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 153 shares during the period. Cromwell Holdings LLC lifted its stake in shares of Align Technology by 2,900.0% in the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 174 shares during the period. Center for Financial Planning Inc. acquired a new position in shares of Align Technology in the 1st quarter valued at $35,000. Finally, SVB Wealth LLC bought a new stake in shares of Align Technology in the 1st quarter valued at $36,000. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.